Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 08, 2026
Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 08, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 22, 2025
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 08, 2025
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study.
Journal: EJNMMI research
Published: August 15, 2023
The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 01, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026